The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Insurance & coverage · continued

Coverage for the indication versus for the drug posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

FP
f.petrovTL216 Apr 2025#31
j.nwosu, post #30: I would keep coverage and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly. Go to post

This follows post #30 rather than contradicting it.

Source for the coverage figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.

Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.

0 likes in reply to #30 15mo
VM
v.milanoviTL3Regular17 Apr 2025#32
d.bramley, post #7: Coverage is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at. Go to post

Understood. Thank you for being specific about the limits of it.

1 like in reply to #7 15mo
PF
p.friskTL218 Apr 2025 · edited#33

Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.

11 likes 15mo
ID
integrator_draftTL3Regular18 Apr 2025#34

Coming back to post #33, because the follow-up matters more than the original answer.

Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.

24 likes 15mo
KB
ka.batistaTL219 Apr 2025#35

Taking post #34 at face value and following it one step further.

What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

0 likes 15mo
SF
sterile_fileTL3Regular20 Apr 2025#36
h.jansen, post #4: This is the sort of exchange that makes the archive worth searching. Go to post

Post #33 and I disagree about the size of the effect, not about the direction.

The useful distinction on coverage is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.

3 likes in reply to #4 15mo
NC
n.chowdhuryTL221 Apr 2025#37

Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.

Not a strong opinion, just a consistent one.

16 likes 15mo
AS
a.stephanopoulosTL3Regular22 Apr 2025#38

Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.

32 likes 15mo
LF
l.ferreiraTL223 Apr 2025#39
j.nwosu, post #30: I would keep coverage and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly. Go to post

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

1 like in reply to #30 15mo
ES
e.silvaTL224 Apr 2025#40

Post #36 describes the usual case. This is about the unusual one.

Where coverage was granted, saying what the successful submission contained is one of the more useful posts on the site.

6 likes 15mo
EN
e.nilsenTL224 Apr 2025#41
KB
k.brandl_deTL3Translator · DE25 Apr 2025#42

Agreed on all of that, and I have nothing to add to it.

0 likes 15mo
AK
a.krastevTL226 Apr 2025#43

Answering the question post #40 raises rather than the one it answers.

One more thing on coverage that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

17 likes 15mo
AL
aliquot_lineTL3Regular27 Apr 2025#44
sterile_file, post #36: Post #33 and I disagree about the size of the effect, not about the direction. The useful distinction on coverage is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars. Go to post

The arithmetic in post #43 is right; the assumption feeding it is the part to check.

I would call the community position on coverage likely rather than established, and I would be comfortable defending that hedge.

7 likes in reply to #36 15mo
AV
a.vestergaardTL228 Apr 2025#45
e.coelho, post #22: What I want from this coverage thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it. Go to post

Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.

That is what I would do. It may not be what is correct.

0 likes in reply to #22 15mo
G
GEldridgeTL3Regular29 Apr 2025#46

Summarising the coverage thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.

25 likes 15mo
LK
l.krastevTL230 Apr 2025 · edited#47

Coverage for the device and for the compound can be decided separately, which surprises people at the pharmacy counter.

If it helps: the failure mode here is usually boring rather than dramatic.

12 likes 15mo
GD
glossary_deskTL3Regular30 Apr 2025#48
integrator_draft, post #34: Coming back to post #33, because the follow-up matters more than the original answer. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift. Go to post

Adding the measurement that post #45 says would settle it.

Since coverage keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.

4 likes in reply to #34 15mo
SP
s.perrinTL21 May 2025#49
l.ferreira, post #39: Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. Go to post

Second this, and I would have said it less carefully.

3 likes in reply to #39 15mo
GC
glossary_checkTL2Member2 May 2025#50

Taking post #48 at face value and following it one step further.

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

0 likes 15mo
ID
il.dumitruTL23 May 2025#51
n.chowdhury, post #37: Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Not a strong opinion, just a consistent one. Go to post

Quantity limits are a separate decision from coverage and have their own exception route.

Happy to be corrected if someone holds better data than mine.

2 likes in reply to #37 15mo
GH
g.haalandTL3Regular4 May 2025#52
s.perrin, post #49: Second this, and I would have said it less carefully. Go to post

Having read the whole coverage thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.

8 likes in reply to #49 15mo
IO
i.oseiTL24 May 2025 · edited#53

Coverage looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

19 likes 15mo
O
OkaforTL3Regular5 May 2025#54

That is the distinction I keep failing to hold on to. Written down now.

0 likes 15mo
SO
s.oyelaranTL26 May 2025#55

Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.

It cost nothing to check and would have cost something not to.

0 likes 15mo
O
OTeixeiraTL3Regular7 May 2025#56
erratum_file, post #3: Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy. That has been true for the cases I have seen and I have not seen many. Go to post

The practical version of coverage is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.

4 likes in reply to #3 15mo
NZ
n.zielinskiTL28 May 2025#57

The arithmetic in post #56 is right; the assumption feeding it is the part to check.

Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.

13 likes 15mo
M
MJayawardenaTL38 May 2025#58
BT
b.teixeiraTL29 May 2025#59
j.nwosu, post #30: I would keep coverage and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly. Go to post

Picking up post #56: that is the part I would want checked first.

Posting my coverage numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.

7 likes in reply to #30 15mo
EM
endpoint_marginTL2Member10 May 2025 · edited#60

On post #59 — agreed on the reasoning, with one qualification.

Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.

18 likes 15mo